On the contrary, I would suggest that it is in the process of "trying to align
morphologic descriptions with specific immunophenotypes" that we make progress
in sorting out which morphologies and which immunophenotypes actually define
true pathological entities.
Granted, we may do ourselves and our clinical colleagues a disservice if we
"invent" new diseases solely upon the merit of immunologic variations...but
the efforts to correlate these various criteria (morphologic, immunologic,
genetic, and clinical) clearly result in the recognition and better
understanding of specific disease entities.
***************************************************************
Christopher R. Conley, MD conley.christopher@mayo.edu
Dept. of Pathology Tel:(602)301-8021 FAX:(602)301-8372
Mayo Clinic Scottsdale 13400 E. Shea Blvd. Scottsdale AZ 85259
CD-ROM Vol 3 was produced by Monica M. Shively and other staff at the
Purdue University Cytometry Laboratories and distributed free of charge
as an educational service to the cytometry community.
If you have any comments please direct them to
Dr. J. Paul Robinson, Professor & Director,
PUCL, Purdue University, West Lafayette, IN 47907.
Phone: (765)-494-0757;
FAX(765) 494-0517;
Web